Stage I Retinoblastoma

Oncology

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Stage I Retinoblastoma?

There are 1 clinical trial targeting Stage I Retinoblastoma tracked by BioSniper.

What is the prevalence of Stage I Retinoblastoma?

The estimated prevalence of Stage I Retinoblastoma is approximately 0.1 per 100,000 population.

Deep-dive into Stage I Retinoblastoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Stage I Retinoblastoma — Drugs in Development & Clinical Trials | BioSniper